Page last updated: 2024-09-05

phosphatidylcholines and Leukemia, Lymphocytic, Chronic, B-Cell

phosphatidylcholines has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batliwalla, F; Chen, SS; Chiorazzi, N; Croce, CM; Holodick, NE; Rothstein, TL; Yan, XJ; Yancopoulos, S	1

Other Studies

1 other study(ies) available for phosphatidylcholines and Leukemia, Lymphocytic, Chronic, B-Cell

Article	Year
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling. Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-16, Volume: 110, Issue:16 Topics: Animals; Autoantigens; B-Lymphocytes; Cell Proliferation; Gene Expression Profiling; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Transfusion; Mice; Mice, SCID; Mice, Transgenic; Phosphatidylcholines; Proto-Oncogene Proteins; Receptors, Antigen, B-Cell; Selection, Genetic; Signal Transduction; V(D)J Recombination	2013

Article

Year

Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.

Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-16, Volume: 110, Issue:16

Topics: Animals; Autoantigens; B-Lymphocytes; Cell Proliferation; Gene Expression Profiling; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Transfusion; Mice; Mice, SCID; Mice, Transgenic; Phosphatidylcholines; Proto-Oncogene Proteins; Receptors, Antigen, B-Cell; Selection, Genetic; Signal Transduction; V(D)J Recombination

2013